Bonn researchers elucidate a mechanism underlying cisplatin resistance in testicular cancer
Cisplatin is used successfully in the chemotherapy of testicular cancer. However, patients who develop resistance to the cytostatic drug urgently need alternative therapy options.
Source: news-medical.net